NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required) (PAR-23-057)

Sponsor: National Institute on Aging

Due Date: Multiple due dates; see announcement.

FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed) (PAR-23-072)

Sponsor: Food and Drug Administration

Due Date: Multiple due dates; see announcement.

Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional) (PAR-23-054)

Sponsor: National Institute on Aging, Office of Research on Women's Health

Due Date: Multiple due dates; see announcement.

Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional) (PAR-23-053)

Sponsor: National Institute on Aging, Office of Research on Women's Health

Due Date: Multiple due dates; see announcement.

Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional) (PAR-24-022)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement Clinical Trial Optional) (PA-23-044)

Sponsor: National Institutes of Health

Due Date: See announcement.

Development of Animal Models and Related Biological Materials for Down Syndrome Research (R24 Clinical Trials Not-Allowed) (PAR-22-247)

Sponsor: National Institutes of Health

Award: The National Institutes of Health (NIH) intends to commit $1.5 million per fiscal year in FY2023-2026 to fund at least two awards per fiscal year.

Due Date: Multiple due dates; see announcement.

Notice of Special Interest: Development of Radiotracers for Diagnosis and Clinical Studies in Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (NOT-AG-22-032)

Sponsor: National Institute on Aging

Due Date: See announcement for due dates and associated Funding Opportunity Announcements.

Resource-Related Research Projects for Development of Animal Models and Related Materials (R24 Clinical Trials Not-Allowed) (RFA-OD-22-013)

Sponsor: National Institutes of Health

Award: The National Institutes of Health (NIH) intends to commit $5,000,000 per fiscal year in FY 2023-2026 to fund at least six awards per fiscal year.

Due Date: Multiple due dates; see announcement.

Notice of Special Interest (NOSI): Research on the Health of Bisexual and Bisexual+ People (NOT-OD-22-166)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional) (PAR-22-213)

Sponsor: National Institute on Aging

Due Date: Multiple due dates; see announcement.

Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) (PAS-22-196)

Sponsor: National Institute on Aging National Institute of Neurological Disorders and Stroke

Due Date: Multiple due dates; see announcement.

Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional) (PAS-22-197)

Sponsor: National Institute on Aging National Institute of Neurological Disorders and Stroke

Due Date: Multiple due dates; see announcement.

NIDA, NIMH, and NINDS Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional) (PAR-22-181)

Sponsor: National Institutes of Health

Award: NINDS intends to commit up to $10 million per fiscal year, approximately 25 awards, dependent on award amounts.

Due Date: Multiple due dates; see announcement.

Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01 Clinical Trial Not Allowed) (PAR-22-184)

Sponsor: National Institute of Neurological Disorders and Stroke, National Center for Advancing Translational Sciences

Due Date: Multiple due dates; see announcement.